Clinical Research Directory
Browse clinical research sites, groups, and studies.
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Sponsor: Duke University
Summary
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Official title: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
750
Start Date
2025-10-28
Completion Date
2027-04-01
Last Updated
2026-04-08
Healthy Volunteers
No
Interventions
(IRIS-CKD Screening Program): Home Kit
All participants approached for enrollment in Program 1 will receive National Kidney Foundational educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab(s) results. Home Test Kit: a kit delivered to participants homes with instructions to complete eGFR (fingerstick) and/or UACR (urine sample) testing, depending on which lab(s) are missing at baseline.
(IRIS-CKD Screening Program): Standard Lab Order
ll participants approached for enrollment in Program 1 will receive National Kidney Foundation educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab
Locations (6)
University of Alabama
Birmingham, Alabama, United States
Orlando Health
St. Petersburg, Florida, United States
University of Michigan
Ann Arbor, Michigan, United States
Essentia Health
Duluth, Minnesota, United States
Duke University
Durham, North Carolina, United States
Baylor Scott & White
Temple, Texas, United States